{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:12:46Z","timestamp":1792080766524,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s40618-015-0399-z","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T11:35:42Z","timestamp":1445945742000},"page":"439-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anastrozole plus leuprorelin in early maturing girls with compromised growth: the \u201cGAIL\u201d study"],"prefix":"10.1007","volume":"39","author":[{"given":"D. T.","family":"Papadimitriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dermitzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Papagianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Papaevangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"399_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mce.2006.04.031","volume":"254\u2013255","author":"L Dunkel","year":"2006","unstructured":"Dunkel L (2006) Use of aromatase inhibitors to increase final height. Mol Cell Endocrinol 254\u2013255:207\u2013216. doi: 10.1016\/j.mce.2006.04.031","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 1","key":"399_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000178040","volume":"71","author":"L Dunkel","year":"2009","unstructured":"Dunkel L (2009) Update on the role of aromatase inhibitors in growth disorders. Horm Res 71(Suppl 1):57\u201363. doi: 10.1159\/000178040","journal-title":"Horm Res"},{"issue":"9270","key":"399_CR3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0140-6736(00)04895-9","volume":"357","author":"S Wickman","year":"2001","unstructured":"Wickman S, Sipila I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L (2001) A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet 357(9270):1743\u20131748. doi: 10.1016\/S0140-6736(00)04895-9","journal-title":"Lancet"},{"issue":"12","key":"399_CR4","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","volume":"90","author":"M Hero","year":"2005","unstructured":"Hero M, Norjavaara E, Dunkel L (2005) Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab 90(12):6396\u20136402. doi: 10.1210\/jc.2005-1392","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"399_CR5","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1210\/jc.2014-2432","volume":"99","author":"EK Neely","year":"2014","unstructured":"Neely EK, Kumar RB, Payne SL, Ranadive SA, Suchet DI (2014) Letrozole vs anastrozole for height augmentation in short pubertal males: first year data. J Clin Endocrinol Metab 99(11):4086\u20134093. doi: 10.1210\/jc.2014-2432","journal-title":"J Clin Endocrinol Metab"},{"key":"399_CR6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1687-9856-2015-4","volume":"1","author":"A Rothenbuhler","year":"2015","unstructured":"Rothenbuhler A, Linglart A, Bougneres P (2015) A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature. Int J Pediatr Endocrinol 1:4. doi: 10.1186\/1687-9856-2015-4","journal-title":"Int J Pediatr Endocrinol"},{"issue":"12","key":"399_CR7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1515\/JPEM.2004.17.12.1597","volume":"17","author":"N Mauras","year":"2004","unstructured":"Mauras N, Welch S, Rini A, Klein KO (2004) An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys. J Pediatr Endocrinol Metab JPEM 17(12):1597\u20131606","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"issue":"10","key":"399_CR8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/JPEM.2008.21.10.995","volume":"21","author":"S Eyssette-Guerreau","year":"2008","unstructured":"Eyssette-Guerreau S, Pinto G, Sultan A, Le Merrer M, Sultan C, Polak M (2008) Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. J Pediatr Endocrinol Metab JPEM 21(10):995\u20131002","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"issue":"9","key":"399_CR9","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1210\/jc.2004-0082","volume":"89","author":"PV Plourde","year":"2004","unstructured":"Plourde PV, Reiter EO, Jou HC, Desrochers PE, Rubin SD, Bercu BB, Diamond FB Jr, Backeljauw PF (2004) Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89(9):4428\u20134433. doi: 10.1210\/jc.2004-0082","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"399_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000079882","volume":"62","author":"FG Riepe","year":"2004","unstructured":"Riepe FG, Baus I, Wiest S, Krone N, Sippell WG, Partsch CJ (2004) Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole. Horm Res 62(3):113\u2013118. doi: 10.1159\/000079882","journal-title":"Horm Res"},{"issue":"4","key":"399_CR11","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1542\/peds.2007-2081","volume":"121","author":"DI Shulman","year":"2008","unstructured":"Shulman DI, Francis GL, Palmert MR, Eugster EA, Drug ftLWPES, Committee T, (2008) Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics 121(4):e975\u2013e983. doi: 10.1542\/peds.2007-2081","journal-title":"Pediatrics"},{"issue":"7","key":"399_CR12","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1210\/jc.2007-2090","volume":"93","author":"J Mieszczak","year":"2008","unstructured":"Mieszczak J, Lowe ES, Plourde P, Eugster EA (2008) The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune\u2013Albright syndrome. J Clin Endocrinol Metab 93(7):2751\u20132754. doi: 10.1210\/jc.2007-2090","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"399_CR13","first-page":"897","volume":"15","author":"N Albers","year":"2002","unstructured":"Albers N, Jorgens S, Deiss D, Hauffa BP (2002) McCune-Albright syndrome\u2014the German experience. J Pediatr Endocrinol Metab JPEM 15(Suppl 3):897\u2013901","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"issue":"3\u20134","key":"399_CR14","first-page":"323","volume":"25","author":"C Alves","year":"2012","unstructured":"Alves C, Silva SF (2012) Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune\u2013Albright syndrome. J Pediatr Endocrinol Metab JPEM 25(3\u20134):323\u2013325","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"issue":"9","key":"399_CR15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s12098-009-0190-2","volume":"76","author":"O Engiz","year":"2009","unstructured":"Engiz O, Berberoglu M, Siklar Z, Bilir P, Ocal G (2009) Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy. Indian J Pediatr 76(9):950\u2013951. doi: 10.1007\/s12098-009-0190-2","journal-title":"Indian J Pediatr"},{"issue":"3","key":"399_CR16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ecl.2009.06.004","volume":"38","author":"N Mauras","year":"2009","unstructured":"Mauras N (2009) Strategies for maximizing growth in puberty in children with short stature. Endocrinol Metab Clin North Am 38(3):613\u2013624. doi: 10.1016\/j.ecl.2009.06.004","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"399_CR17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4274\/jcrpe.v1i6.256","volume":"1","author":"ME Geffner","year":"2009","unstructured":"Geffner ME (2009) Aromatase inhibitors to augment height: continued caution and study required. J Clin Res Pediatr Endocrinol 1(6):256\u2013261. doi: 10.4274\/jcrpe.v1i6.256","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"399_CR18","doi-asserted-by":"crossref","unstructured":"Papadimitriou DT, Papadimitriou A (2010) An open label 1\u20133\u00a0year clinical trial on the effects of the aromatase inhibitor Anastrazole combined to the LHRH analogue Leuprorelin in girls with compromised growth potential. Paper presented at the Endocrine Society Meeting, San Diego","DOI":"10.1210\/endo-meetings.2010.PART3.P14.P3-688"},{"issue":"10","key":"399_CR19","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jcem.84.10.6032","volume":"84","author":"C Bouvattier","year":"1999","unstructured":"Bouvattier C, Coste J, Rodrigue D, Teinturier C, Carel JC, Chaussain JL, Bougneres PF (1999) Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab 84(10):3575\u20133578. doi: 10.1210\/jcem.84.10.6032","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"399_CR20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2014.40","volume":"10","author":"RH Willemsen","year":"2014","unstructured":"Willemsen RH, Elleri D, Williams RM, Ong KK, Dunger DB (2014) Pros and cons of GnRHa treatment for early puberty in girls. Nat Rev Endocrinol 10(6):352\u2013363. doi: 10.1038\/nrendo.2014.40","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"399_CR21","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1210\/jc.2008-0661","volume":"93","author":"A Papadimitriou","year":"2008","unstructured":"Papadimitriou A, Pantsiotou S, Douros K, Papadimitriou DT, Nicolaidou P, Fretzayas A (2008) Timing of pubertal onset in girls: evidence for non-Gaussian distribution. J Clin Endocrinol Metab 93(11):4422\u20134425. doi: 10.1210\/jc.2008-0661","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"399_CR22","first-page":"485","volume":"55","author":"O Tarim","year":"2013","unstructured":"Tarim O (2013) Height predictions by Bayley\u2013Pinneau method may misguide pediatric endocrinologists. Turk J Pediatr 55(5):485\u2013492","journal-title":"Turk J Pediatr"},{"issue":"2","key":"399_CR23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1542\/peds.68.2.251","volume":"68","author":"JL Kirkland","year":"1981","unstructured":"Kirkland JL, Gibbs AR, Kirkland RT, Clayton GW (1981) Height predictions in girls with idiopathic precocious puberty by the Bayley\u2013Pinneau method. Pediatrics 68(2):251\u2013252","journal-title":"Pediatrics"},{"issue":"Suppl 3","key":"399_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000053164","volume":"51","author":"JC Carel","year":"1999","unstructured":"Carel JC, Chaussain JL (1999) Gonadotropin releasing hormone agonist treatment for central precocious puberty. Horm Res Paediatr 51(Suppl 3):64\u201369","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"399_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000330005","volume":"76","author":"A Papadimitriou","year":"2011","unstructured":"Papadimitriou A, Kanakis G, Douros K, Papadimitriou DT, Boutsiadis AH, Nicolaidou P, Fretzayas A (2011) Constitutional advancement of growth is associated with early puberty in girls. Horm Res Paediatr 76(4):273\u2013277. doi: 10.1159\/000330005","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"399_CR26","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/annonc\/mdr017","volume":"22","author":"P Hadji","year":"2011","unstructured":"Hadji P, Aapro MS, Body JJ, Bundred NJ, Brufsky A, Coleman RE, Gnant M, Guise T, Lipton A (2011) Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Ann Oncol 22(12):2546\u20132555. doi: 10.1093\/annonc\/mdr017","journal-title":"Ann Oncol"},{"issue":"4","key":"399_CR27","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","volume":"123","author":"J-C Carel","year":"2009","unstructured":"Carel J-C, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, Group obotmotE-LGACC (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123(4):e752\u2013e762. doi: 10.1542\/peds.2008-1783","journal-title":"Pediatrics"},{"issue":"suppl 2","key":"399_CR28","first-page":"140","volume":"62","author":"ALPJ Turpin","year":"2004","unstructured":"Turpin ALPJ, Karmazin A, Moore WV, Jacobson JD (2004) Aromatase inhibitor may delay skeletal maturation and improve final adult height in females. Horm Res 62(suppl 2):140\u2013198. doi: 10.1159\/000081147","journal-title":"Horm Res"},{"issue":"3","key":"399_CR29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000091592","volume":"65","author":"DT Papadimitriou","year":"2006","unstructured":"Papadimitriou DT, Linglart A, Morel Y, Chaussain JL (2006) Puberty in subjects with complete androgen insensitivity syndrome. Horm Res 65(3):126\u2013131. doi: 10.1159\/000091592","journal-title":"Horm Res"},{"issue":"2","key":"399_CR30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H, Network NRM (2014) Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 371(2):119\u2013129. doi: 10.1056\/NEJMoa1313517","journal-title":"N Engl J Med"},{"issue":"6","key":"399_CR31","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.fertnstert.2012.10.008","volume":"98","author":"RF Casper","year":"2012","unstructured":"Casper RF, Mitwally MF (2012) A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril 98(6):1352\u20131355. doi: 10.1016\/j.fertnstert.2012.10.008","journal-title":"Fertil Steril"},{"issue":"5","key":"399_CR32","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.fertnstert.2009.09.032","volume":"94","author":"N Winkler","year":"2010","unstructured":"Winkler N, Bukulmez O, Hardy DB, Carr BR (2010) Gonadotropin releasing hormone antagonists suppress aromatase and anti-Mullerian hormone expression in human granulosa cells. Fertil Steril 94(5):1832\u20131839. doi: 10.1016\/j.fertnstert.2009.09.032","journal-title":"Fertil Steril"},{"issue":"12","key":"399_CR33","first-page":"4677","volume":"84","author":"MM Grumbach","year":"1999","unstructured":"Grumbach MM, Auchus RJ (1999) Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 84(12):4677\u20134694. doi: 10.1210\/jcem.84.12.6290","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"399_CR34","first-page":"1189","volume":"20","author":"GJ Kunz","year":"2007","unstructured":"Kunz GJ, Sherman TI, Klein KO (2007) Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment? J Pediatr Endocrinol Metab JPEM 20(11):1189\u20131198","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"issue":"10","key":"399_CR35","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1210\/jc.2010-0895","volume":"95","author":"A Papadimitriou","year":"2010","unstructured":"Papadimitriou A, Nicolaidou P, Fretzayas A, Chrousos GP (2010) Clinical review: Constitutional advancement of growth, a.k.a. early growth acceleration, predicts early puberty and childhood obesity. J Clin Endocrinol Metab 95(10):4535\u20134541. doi: 10.1210\/jc.2010-0895","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"399_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humupd\/dmh012","volume":"10","author":"JC Carel","year":"2004","unstructured":"Carel JC, Lahlou N, Roger M, Chaussain JL (2004) Precocious puberty and statural growth. Human Reprod Update 10(2):135\u2013147. doi: 10.1093\/humupd\/dmh012","journal-title":"Human Reprod Update"},{"issue":"5","key":"399_CR37","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1210\/jcem.87.5.8481","volume":"87","author":"L Lazar","year":"2002","unstructured":"Lazar L, Kauli R, Pertzelan A, Phillip M (2002) Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab 87(5):2090\u20132094. doi: 10.1210\/jcem.87.5.8481","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"399_CR38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000208803","volume":"71","author":"M Hero","year":"2009","unstructured":"Hero M, Makitie O, Kroger H, Nousiainen E, Toiviainen-Salo S, Dunkel L (2009) Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature. Horm Res 71(5):290\u2013297. doi: 10.1159\/000208803","journal-title":"Horm Res"},{"issue":"5","key":"399_CR39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-13-0864","volume":"170","author":"I Flechtner","year":"2014","unstructured":"Flechtner I, Lambot-Juhan K, Teissier R, Colmenares A, Baujat G, Beltrand J, Ajaltouni Z, Pauwels C, Pinto G, Samara-Boustani D, Simon A, Thalassinos C, Le Merrer M, Cormier-Daire V, Polak M (2014) Unexpected high frequency of skeletal dysplasia in idiopathic short stature and small for gestational age patients. Eur J Endocrinol\/Eur Fed Endocr Soc 170(5):677\u2013684. doi: 10.1530\/EJE-13-0864","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0399-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0399-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T14:00:07Z","timestamp":1653400807000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0399-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0399-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]}}}